A Study of SC-006 and in Combination With ABBV-181 in Subjects With Advanced Colorectal Cancer
Public ClinicalTrials.gov record NCT03035279. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Label Phase 1 Study of SC-006 as a Single Agent and in Combination With ABBV-181 in Subjects With Advanced Colorectal Cancer
Study identification
- NCT ID
- NCT03035279
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 29 participants
Conditions and interventions
Conditions
Interventions
- ABBV-181 Drug
- SC-006 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 7, 2017
- Primary completion
- Mar 27, 2019
- Completion
- Mar 27, 2019
- Last update posted
- Feb 19, 2020
2017 – 2019
United States locations
- U.S. sites
- 9
- U.S. states
- 9
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Highlands Oncology Group /ID# 201182 | Fayetteville | Arkansas | 72703-4005 | — |
| University of California, Los Angeles /ID# 160882 | Los Angeles | California | 90095 | — |
| University of Michigan Hospitals /ID# 167101 | Ann Arbor | Michigan | 48109-5008 | — |
| Mayo Clinic - Rochester /ID# 160884 | Rochester | Minnesota | 55905-0001 | — |
| Washington University-School of Medicine /ID# 160883 | St Louis | Missouri | 63110 | — |
| Memorial Sloan Kettering Cancer Center /ID# 160881 | New York | New York | 10065-6007 | — |
| Carolina BioOncology Institute /ID# 202712 | Huntersville | North Carolina | 28078 | — |
| Oklahoma University /ID# 202713 | Oklahoma City | Oklahoma | 73104 | — |
| Tennessee Oncology-Nashville Centennial /ID# 160880 | Nashville | Tennessee | 37203-1632 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03035279, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 19, 2020 · Synced May 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03035279 live on ClinicalTrials.gov.